Developer docs
API playgroundTry for free, no card

Search company profiles

Hemoteq

Full company profile

uuid000eany

Namestring
Hemoteq
Legal namestring
Hemoteq
Websiteurl
hemoteq.de
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Hemoteq AG, founded in 1999 and headquartered in Würselen, Germany, is a developer of specialized coating technologies for medical combination products. The company operates as a wholly-owned product brand under Freudenberg Medical, having been acquired in 2015 and fully integrated in 2025. Its portfolio centers on two proprietary technology lines: Hemoteq drug coatings, which deliver controlled release of active pharmaceutical ingredients for drug-eluting stents, drug-coated balloons, and non-vascular implants; and LUBRITEQ, a UV-curable hydrophilic coating that reduces surface friction for minimally invasive devices. The underlying technology is built on in-house excipient and drug formulations protected by 100+ patents, supported by automated coating machines with proprietary software for repeatable precision and surface modification capabilities including plasma treatment and physical microstructuring.

The business operates as a Contract Development and Manufacturing Organization (CDMO), generating revenue through three streams: volume contract coating services at Freudenberg Medical facilities in Germany, the United States, and Ireland; sale of proprietary coating products as powder or solution for in-house customer application; and coating technology development, process development, and technology transfer services. Pricing is quote-based and structured around multi-year enterprise contracts, with royalty-free models available to reduce long-term customer cost. Customers are primarily medical device OEMs in cardiovascular, interventional, and minimally invasive surgical segments, with a secondary pharmaceutical customer segment for drug-device combination products. GTM is enterprise field sales, supported by digital channels (Freudenberg Medical website, LinkedIn, YouTube, WeChat) and a Knowledge Hub of whitepapers, brochures, and webinars.

The company's competitive position rests on regulatory-grade, clinically validated coatings aligned with FDA, ISO, and MDR requirements, plus vertical integration into Freudenberg Medical's 12-site global manufacturing footprint and 250+-engineer development organization. Key named customer evidence includes a flagship relationship with a leading cardiovascular medical device company for drug-coated balloon catheters, addressing cardiovascular disease which accounts for 30% of global deaths.

Short descriptiontext

Hemoteq, a wholly-owned Freudenberg Medical product brand founded in 1999 and based in Germany, develops proprietary drug and hydrophilic coatings for drug-device combination products, serving medical device OEMs and pharmaceutical companies through CDMO services and powder/solution product sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersWürselen, Germany
HQ citystring
Würselen
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device coatings, drug-device combination products, hydrophilic coatings, drug eluting coatings, medical surface modifications
Industry1 code
PRIMARYIMAIAKAM
Specialty & Functional Coatings (Anti-microbial/Anti-slip/Insulating)
Industrials, Manufacturing & Construction/Industrial Services & Facility Operations/Industrial & Commercial Painting, Coating & Surface Treatment
NAICS code2 codes
  • Paint and Coating Manufacturing32551
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Coating, Engraving & Allied Services3470
Product category
Medical Device Coatings
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Coating Products (Powder/Solution)
TypeOthers
Description

Customers can purchase proprietary coatings as powder or solution to apply in-house at their own facilities

freudenbergmedical.com
2Contract Coating Services
TypeProfessional Services
Description

Volume coating production services at Freudenberg facilities in U.S., Ireland, or Germany for medical devices and components

freudenbergmedical.com
3Coating Technology Development
TypeProfessional Services
Description

Coating design, process development, iterative prototyping, pilot production, and technology transfer services for drug-device combination products

freudenbergmedical.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure
Pricing details1 tier
1Custom CDMO coating services - quote-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing determined based on project requirements, volume, and specific coating needs

freudenbergmedical.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Hemoteq develops and manufactures proprietary medical coating solutions for drug-device combination products (DDCP), including drug coatings for drug eluting stents, drug coated balloons, and non-vascular implants. It also provides advanced UV-curable hydrophilic coatings (under the LUBRITEQ brand) and surface modification services for minimally-invasive medical devices. Offerings include both coating products sold as powder/solution for in-house application and contract coating services performed at Freudenberg Medical facilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Reduced surface friction and exceptional lubricity for minimally-invasive devices
+3 more records
Product overview1 text field

Hemoteq is an established product brand under Freudenberg Medical focused on drug coatings for medical devices. The portfolio includes two main product lines: Hemoteq for drug coatings and LUBRITEQ™ for advanced hydrophilic coatings solutions. These offerings are part of Freudenberg Medical's broader CDMO (Contract Development and Manufacturing Organization) services for drug-device combination products, providing coating design, process development, regulatory strategy, and volume production of specialty coated components.

Product and service5 records
1Hemoteq Drug Coatings
CategoryDrug-Device Combination Products
Description

Proprietary drug coating formulations for drug-device combination products, enabling controlled and precise delivery of active pharmaceutical ingredients with specified release profiles for optimal clinical performance. Designed for medical device OEMs developing interventional cardiovascular devices and implants.

2LUBRITEQ Hydrophilic Coatings
CategoryHydrophilic Coatings
Description

UV-curable hydrophilic coating solution for medical devices that reduces surface friction and delivers exceptional lubricity for minimally-invasive medical devices. Validated in clinical applications and aligned with FDA, ISO, and MDR regulatory requirements.

3Surface Modifications
CategorySurface Engineering
Description

Tailored surface property modification services including wettability control, friction reduction, anti-tack properties, and controlled drug release. Uses physical microstructuring, plasma treatment, and proprietary drop-drag-coating processes for medical device manufacturers.

4Automated Coating Machines
CategoryCoating Equipment
Description

Automated coating machinery with proprietary software and calibratable coating settings designed to ensure coating consistency, precision, and reliability for medical device manufacturing.

5Contract Coating Services
CategoryContract Manufacturing Services
Description

Contract Development and Manufacturing Organization (CDMO) services for medical device coatings, including coating design, process development, iterative prototyping, pilot production, technology transfer, and volume coating production for medical devices and components.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Hemoteq AG
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2015-01-01
Description

Freudenberg Medical acquired Hemoteq in 2015 to strategically expand expertise in medical coatings. The acquisition brought proprietary drug coating formulations, 25+ years of coating expertise, and established market presence in drug-device combination products. Full integration was completed in 2025, enabling Freudenberg to offer development, manufacturing, and coating from a single source.

freudenbergmedical.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hemoteq

Medical Device Coatingshemoteq.de

Hemoteq, a wholly-owned Freudenberg Medical product brand founded in 1999 and based in Germany, develops proprietary drug and hydrophilic coatings for drug-device combination products, serving medical device OEMs and pharmaceutical companies through CDMO services and powder/solution product sales.

What Hemoteq does

Hemoteq AG, founded in 1999 and headquartered in Würselen, Germany, is a developer of specialized coating technologies for medical combination products. The company operates as a wholly-owned product brand under Freudenberg Medical, having been acquired in 2015 and fully integrated in 2025. Its portfolio centers on two proprietary technology lines: Hemoteq drug coatings, which deliver controlled release of active pharmaceutical ingredients for drug-eluting stents, drug-coated balloons, and non-vascular implants; and LUBRITEQ, a UV-curable hydrophilic coating that reduces surface friction for minimally invasive devices. The underlying technology is built on in-house excipient and drug formulations protected by 100+ patents, supported by automated coating machines with proprietary software for repeatable precision and surface modification capabilities including plasma treatment and physical microstructuring.

The business operates as a Contract Development and Manufacturing Organization (CDMO), generating revenue through three streams: volume contract coating services at Freudenberg Medical facilities in Germany, the United States, and Ireland; sale of proprietary coating products as powder or solution for in-house customer application; and coating technology development, process development, and technology transfer services. Pricing is quote-based and structured around multi-year enterprise contracts, with royalty-free models available to reduce long-term customer cost. Customers are primarily medical device OEMs in cardiovascular, interventional, and minimally invasive surgical segments, with a secondary pharmaceutical customer segment for drug-device combination products. GTM is enterprise field sales, supported by digital channels (Freudenberg Medical website, LinkedIn, YouTube, WeChat) and a Knowledge Hub of whitepapers, brochures, and webinars.

The company's competitive position rests on regulatory-grade, clinically validated coatings aligned with FDA, ISO, and MDR requirements, plus vertical integration into Freudenberg Medical's 12-site global manufacturing footprint and 250+-engineer development organization. Key named customer evidence includes a flagship relationship with a leading cardiovascular medical device company for drug-coated balloon catheters, addressing cardiovascular disease which accounts for 30% of global deaths.

Hemoteq firmographics

Firmographics
Name
Hemoteq
Legal name
Hemoteq
Website
https://hemoteq.de
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Hemoteq, a wholly-owned Freudenberg Medical product brand founded in 1999 and based in Germany, develops proprietary drug and hydrophilic coatings for drug-device combination products, serving medical device OEMs and pharmaceutical companies through CDMO services and powder/solution product sales.
Ownership category
akta.pro rank

Hemoteq industry classification

Industry
Product category
Medical Device Coatings
NAICS
Paint and Coating Manufacturing (32551), Medical Equipment and Supplies Manufacturing (3391)
SIC
Coating, Engraving & Allied Services (3470)
akta.pro industry
PRIMARYIMAIAKAM
Specialty & Functional Coatings (Anti-microbial/Anti-slip/Insulating)
Industrials, Manufacturing & Construction/Industrial Services & Facility Operations/Industrial & Commercial Painting, Coating & Surface Treatment

Keywords

  • Medical device coatings
  • Drug-device combination products
  • Hydrophilic coatings
  • Drug eluting coatings
  • Medical surface modifications

Where Hemoteq is headquartered

Location

Headquarters

HQ city
Würselen
HQ country
Germany
HQ region
Europe

Offices3 records

Markets served

Hemoteq business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure

Revenue model

  1. Coating Products (Powder/Solution): Customers can purchase proprietary coatings as powder or solution to apply in-house at their own facilities
  2. Contract Coating Services: Volume coating production services at Freudenberg facilities in U.S., Ireland, or Germany for medical devices and components
  3. Coating Technology Development: Coating design, process development, iterative prototyping, pilot production, and technology transfer services for drug-device combination products

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom CDMO coating services - quote-based pricing

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Hemoteq product offering

Product offering

Core offering

Hemoteq develops and manufactures proprietary medical coating solutions for drug-device combination products (DDCP), including drug coatings for drug eluting stents, drug coated balloons, and non-vascular implants. It also provides advanced UV-curable hydrophilic coatings (under the LUBRITEQ brand) and surface modification services for minimally-invasive medical devices. Offerings include both coating products sold as powder/solution for in-house application and contract coating services performed at Freudenberg Medical facilities.

Product overview

Hemoteq is an established product brand under Freudenberg Medical focused on drug coatings for medical devices. The portfolio includes two main product lines: Hemoteq for drug coatings and LUBRITEQ™ for advanced hydrophilic coatings solutions. These offerings are part of Freudenberg Medical's broader CDMO (Contract Development and Manufacturing Organization) services for drug-device combination products, providing coating design, process development, regulatory strategy, and volume production of specialty coated components.

Differentiator

Problem solved

Functional benefit

Products and services

  • Hemoteq Drug Coatings Proprietary drug coating formulations for drug-device combination products, enabling controlled and precise delivery of active pharmaceutical ingredients with specified release profiles for optimal clinical performance. Designed for medical device OEMs developing interventional cardiovascular devices and implants.
  • LUBRITEQ Hydrophilic Coatings UV-curable hydrophilic coating solution for medical devices that reduces surface friction and delivers exceptional lubricity for minimally-invasive medical devices. Validated in clinical applications and aligned with FDA, ISO, and MDR regulatory requirements.
  • Surface Modifications Tailored surface property modification services including wettability control, friction reduction, anti-tack properties, and controlled drug release. Uses physical microstructuring, plasma treatment, and proprietary drop-drag-coating processes for medical device manufacturers.
  • Automated Coating Machines Automated coating machinery with proprietary software and calibratable coating settings designed to ensure coating consistency, precision, and reliability for medical device manufacturing.
  • Contract Coating Services Contract Development and Manufacturing Organization (CDMO) services for medical device coatings, including coating design, process development, iterative prototyping, pilot production, technology transfer, and volume coating production for medical devices and components.

Quantifiable outcome

  • Reduced surface friction and exceptional lubricity for minimally-invasive devices
  • +3 more outcomes

Companies that use Hemoteq

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Hemoteq technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Hemoteq partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Hemoteq AGcoreStrategic or Co-development Partner · 1 January 2015Freudenberg Medical acquired Hemoteq in 2015 to strategically expand expertise in medical coatings. The acquisition brought proprietary drug coating formulations, 25+ years of coating expertise, and established market presence in drug-device combination products. Full integration was completed in 2025, enabling Freudenberg to offer development, manufacturing, and coating from a single source.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Hemoteq competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Hemoteq social profiles

Digital presence

Hemoteq financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hemoteq leadership team

Management profile

Number of profiles

Profiles1 record

Hemoteq funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hemoteq M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hemoteq

What does Hemoteq do?

Hemoteq develops and manufactures proprietary medical coating solutions for drug-device combination products (DDCP), including drug coatings for drug eluting stents, drug coated balloons, and non-vascular implants. It also provides advanced UV-curable hydrophilic coatings (under the LUBRITEQ brand) and surface modification services for minimally-invasive medical devices. Offerings include both coating products sold as powder/solution for in-house application and contract coating services performed at Freudenberg Medical facilities.

Is Hemoteq a public or private company?

Hemoteq is a private company. It is classified as corporate owned and is currently operating.

When was Hemoteq founded?

Hemoteq was founded in 1999. It employs 1,001 to 5,000 people.

Where is Hemoteq based?

Hemoteq is headquartered in Würselen, Germany, in the Europe region.

How does Hemoteq make money?

Three revenue lines are on record. Coating Products (Powder/Solution) is the primary driver. The others are contract Coating Services and coating Technology Development.

Does Hemoteq have an API?

No public API is recorded for Hemoteq.

What industry is Hemoteq in?

Hemoteq's product category is Medical Device Coatings. Its primary akta.pro industry code is IMAIAKAM, Specialty & Functional Coatings (Anti-microbial/Anti-slip/Insulating). Its NAICS code is 32551 and its SIC code is 3470.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales